Biomedical research in the U.S. is world-class in part because of a long-standing partnership between universities and the ...
National Institutes of Health slashed overhead costs allowed under its grants to match private foundations, but the two don't ...
Potential delays in clinical trials may result in extended timelines for new drug approvals, and a sudden reduction in ...
The funding agency aims to cap “indirect costs” in biomedical research grants. But this behind-the-scenes work is crucial to making research happen.
Over the past few weeks, the Trump administration has introduced sweeping changes across the federal government that have impacted the federal ...
On February 7, the NIH announced that it would begin capping indirect cost payments for new and existing research grants at 15%.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results